Recent advances in chemoprevention of cancer

Science

Volumn 278, Issue 5340, 1997, Pages 1073-1077

  Hong, Waun Ki ^a   Sporn, Michael B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOID DERIVATIVE; RETINOL PALMITATE; TAMOXIFEN DERIVATIVE;

CANCER; CANCER RISK; CANCER SURGERY; CARCINOGENESIS; DNA DAMAGE; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0000147542     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.278.5340.1073     Document Type: Review

References (53)

1. C. L. Kosary et al., Eds., SEER Cancer Statistics Review, 1973-1992 (NIH Publ. No. 95-2789, National Cancer Institute, Bethesda, MD, 1995).
2. M. B. Sporn, Cancer Res. 51, 6215 (1991); L. W. Wattenberg, ibid. 53, 5890 (1993); P. Greenwald, G. Kelloff, C. Burch-Whitman, B. Kramer, CA Cancer J. Clin. 45, 31 (1995).
3. M. B. Sporn, Cancer Res. 51, 6215 (1991); L. W. Wattenberg, ibid. 53, 5890 (1993); P. Greenwald, G. Kelloff, C. Burch-Whitman, B. Kramer, CA Cancer J. Clin. 45, 31 (1995).
4. M. B. Sporn, Cancer Res. 51, 6215 (1991); L. W. Wattenberg, ibid. 53, 5890 (1993); P. Greenwald, G. Kelloff, C. Burch-Whitman, B. Kramer, CA Cancer J. Clin. 45, 31 (1995).
5. W. H. Clark, Acta Oncol. 34, 3 (1995); G. R. Cunha, S. W. Hayward, R. Dahiya, B. A. Foster, Acta Anat. 155, 63 (1996).
6. W. H. Clark, Acta Oncol. 34, 3 (1995); G. R. Cunha, S. W. Hayward, R. Dahiya, B. A. Foster, Acta Anat. 155, 63 (1996).
7. K. W. Kinzler and B. Vogelstein, Cell 87, 159 (1996).
8. S. M. Prescott and R. L. White, ibid., p. 783.
9. M. Oshima et al., ibid., p. 803.
10. M. Tsujii and R. N. DuBois, ibid. 83, 493 (1995).
11. F. M. Giardello et al., N. Engl. J. Med. 328, 1313 (1993); S. K. Boolbol et al., Cancer Res. 56, 2556 (1996).
12. F. M. Giardello et al., N. Engl. J. Med. 328, 1313 (1993); S. K. Boolbol et al., Cancer Res. 56, 2556 (1996).
13. V. C. Jordan, J. Natl. Cancer Inst. 89, 747 (1997).
14. L. J. Black et al., J. Clin Invest. 93, 63 (1994); P. D. Delmas et al., paper presented at the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997 (abstract OR4-1).
15. L. J. Black et al., J. Clin Invest. 93, 63 (1994); P. D. Delmas et al., paper presented at the 79th Annual Meeting of the Endocrine Society, Minneapolis, MN, June 1997 (abstract OR4-1).
16. M. Sporn et al., paper presented at the 88th Annual Meeting of the American Association for Cancer Research, San Diego, CA, April 1997 (abstract 3538).
17. M. M. Gottardis and V. C. Jordan, Cancer Res. 47, 4020 (1987).
18. M. A. Anzano et al., J. Natl. Cancer Inst. 88, 123 (1996).
19. N. N. Yang, M. Venugopalan, S. Hardikar, A. Glasebrook, Science 273, 1222 (1996).
20. K. Paech et al., ibid. 277, 1508 (1997).
21. G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, J. Gustafsson, Proc. Natl. Acad. Sci. U.S.A. 93, 5925 (1996); G. Kuiper et al., Endocrinology 138, 863 (1997); B. S. Katzenellenbogen and K. S. Korach, ibid., p. 861.
22. G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, J. Gustafsson, Proc. Natl. Acad. Sci. U.S.A. 93, 5925 (1996); G. Kuiper et al., Endocrinology 138, 863 (1997); B. S. Katzenellenbogen and K. S. Korach, ibid., p. 861.
23. G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, J. Gustafsson, Proc. Natl. Acad. Sci. U.S.A. 93, 5925 (1996); G. Kuiper et al., Endocrinology 138, 863 (1997); B. S. Katzenellenbogen and K. S. Korach, ibid., p. 861.
24. M. S. Lucia et al., Cancer Res. 55, 5621 (1995).
25. J. W. Aquilina, J. J. Lipsky, D. G. Bostwick, J. Natl. Cancer Inst. 89, 689 (1997).
26. M. Pollard, P. H. Luckert, M. B. Sporn, Cancer Res. 51, 3610 (1991).
27. D. J. Mangelsdorf et al., Cell 83, 835 (1995); D. J. Mangelsdorf and R. M. Evans, ibid., p. 841.
28. D. J. Mangelsdorf et al., Cell 83, 835 (1995); D. J. Mangelsdorf and R. M. Evans, ibid., p. 841.
29. X. Xu et al., J. Natl. Cancer Inst. 89, 624 (1997).
30. R. Lotan et al., N. Engl. J. Med. 332, 1405 (1995).
31. M. F. Boehm et al., J. Med. Chem. 38, 3146 (1995).
32. M. M. Gottardis et al., Cancer Res. 56, 5566 (1996).
33. L. J. Gudas, in The Retinoids, M. B. Sporn, A. B. Roberts, D. S. Goodman, Eds. (Raven, New York, ed. 2, 1994), pp. 443-520.
34. G. J. Kelloff et al., Cancer Res. 541, 2015S (1994); P. Greenwald, Sci. Am. 275, 64 (Sept. 1996); S. M. Lippman et al., J. Clin. Oncol. 12, 851 (1994).
35. G. J. Kelloff et al., Cancer Res. 541, 2015S (1994); P. Greenwald, Sci. Am. 275, 64 (Sept. 1996); S. M. Lippman et al., J. Clin. Oncol. 12, 851 (1994).
36. G. J. Kelloff et al., Cancer Res. 541, 2015S (1994); P. Greenwald, Sci. Am. 275, 64 (Sept. 1996); S. M. Lippman et al., J. Clin. Oncol. 12, 851 (1994).
37. S. M. Lippman et al., J. Natl. Cancer Inst. 82, 555 (1990).
38. W. K. Hong et al., N. Engl. J. Med. 315, 1501 (1986); J. Gouveia et al., Lancet i, 710 (1983); J. S. Lee et al., J. Clin. Oncol. 12, 937 (1994).
39. W. K. Hong et al., N. Engl. J. Med. 315, 1501 (1986); J. Gouveia et al., Lancet i, 710 (1983); J. S. Lee et al., J. Clin. Oncol. 12, 937 (1994).
40. W. K. Hong et al., N. Engl. J. Med. 315, 1501 (1986); J. Gouveia et al., Lancet i, 710 (1983); J. S. Lee et al., J. Clin. Oncol. 12, 937 (1994).
41. F. L. Meyskens et al., J. Natl. Cancer Inst. 86, 539 (1994).
42. D. Labayle et al., Gastroenterology 101, 635 (1991).
43. L. Mao et al., J. Natl. Cancer Inst. 89, 887 (1997).
44. W. K. Hong et al., N. Engl. J. Med. 323, 795 (1990).
45. V. C. Jordan, in Long-Term Tamoxifen Treatment for Breast Cancer, V. C. Jordan, Ed. (Univ. of Wisconsin Press, Madison, WI, 1994), pp. 257-278.
46. U. Pastorino et al., J. Clin. Oncol. 11, 1216 (1993).
47. Y. Muto et al., N. Engl. J. Med. 334, 1561 (1996).
48. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, ibid. 330, 1029 (1994); G. S. Omenn et al., ibid. 334, 1150 (1996); C. H. Hennekens et al., ibid., p. 1145.
49. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, ibid. 330, 1029 (1994); G. S. Omenn et al., ibid. 334, 1150 (1996); C. H. Hennekens et al., ibid., p. 1145.
50. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group, ibid. 330, 1029 (1994); G. S. Omenn et al., ibid. 334, 1150 (1996); C. H. Hennekens et al., ibid., p. 1145.
51. V. Papadimitrakopoulou et al., paper presented at the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, May 1997 (abstract 1366); D. M. Shin et al., paper presented at the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, May 1997 (abstract 1557).
52. V. Papadimitrakopoulou et al., paper presented at the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, May 1997 (abstract 1366); D. M. Shin et al., paper presented at the 33rd Annual Meeting of the American Society of Clinical Oncology, Denver, CO, May 1997 (abstract 1557).
53. We thank A. D. Morgan for editorial assistance. W.K.H. is an American Cancer Society Clinical Research Professor and the Charles A. LeMaistre Chair in Thoracic Oncology; M.B.S. is the Oscar M. Cohn '34 Professor of Pharmacology and Medicine.